Indication
Stage IVA Squamous Cell Carcinoma of the Oropharynx
2 clinical trials
1 product
5 drugs
Clinical trial
Phase II Randomized Trial of Transoral Surgical Resection Followed by Low-Dose or Standard-Dose IMRT in Resectable p16+ Locally Advanced Oropharynx CancerStatus: Active (not recruiting), Estimated PCD: 2020-11-30
Product
cisplatinDrug
carboplatinClinical trial
An Exploratory Pilot Study of Nab-paclitaxel Based Induction Chemotherapy Followed by Response-Stratified Locoregional Therapy for Patients With Stage III and IV HPV-Related Oropharyngeal Cancer - the OPTIMA HPV TrialStatus: Active (not recruiting), Estimated PCD: 2019-03-31
Drug
AbraxaneDrug
paclitaxelDrug
fluorouracilDrug
hydroxyurea